


Searching News Database: H1N1
HSMN NewsFeed - 20 Jul 2016
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
Viracor-IBT Laboratories, Inc.'s Zika Virus RT-PCR Test Receives Emergency Use Authorization From the FDA
HSMN NewsFeed - 29 Dec 2014
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
Roche receives FDA Emergency Use Authorization for the LightMix(R) Ebola Zaire rRT-PCR Test
HSMN NewsFeed - 13 Jan 2011
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
Nanosphere Receives FDA Clearance for Respiratory Virus Subtyping Test Panel
HSMN NewsFeed - 19 Oct 2010
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
HSMN NewsFeed - 6 Jul 2010
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
Novavax Announces Appointment of Dr. Gregory Glenn as Chief Scientific Officer
HSMN NewsFeed - 22 Jun 2010
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM)
Brain Tunnelgenix Technologies Launched To Harness Discovery of Brain Temperature Tunnel(TM)
HSMN NewsFeed - 9 Feb 2010
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
BioSante Pharmaceuticals Appoints Jeffrey W. Winkelman, Ph.D., J.D., Vice President, Oncology Programs
HSMN NewsFeed - 13 Jan 2010
BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
BioCryst's Partner Shionogi Receives Marketing & Manufacturing Approval For Peramivir in Japan
HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
HSMN NewsFeed - 22 Jul 2009
Medline Awarded Premier Contract for Soaps, Lotions and Waterless Hand Rinses
Medline Awarded Premier Contract for Soaps, Lotions and Waterless Hand Rinses
HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
Additional items found! 5
Members Archive contains
5 additional stories matching:
H1N1
(Password required)
H1N1
(Password required)
